These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 36531267)

  • 1. Microbiota analysis for risk assessment of xenobiotics: toxicomicrobiomics, incorporating the gut microbiome in the risk assessment of xenobiotics and identifying beneficial components for One Health.
    Ampatzoglou A; Gruszecka-Kosowska A; Aguilera-Gómez M
    EFSA J; 2022 Dec; 20(Suppl 2):e200915. PubMed ID: 36531267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporating the Gut Microbiome in the Risk Assessment of Xenobiotics and Identifying Beneficial Components for One Health.
    Ampatzoglou A; Gruszecka-Kosowska A; Torres-Sánchez A; López-Moreno A; Cerk K; Ortiz P; Monteoliva-Sánchez M; Aguilera M
    Front Microbiol; 2022; 13():872583. PubMed ID: 35602014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring Next Generation Probiotics for Metabolic and Microbiota Dysbiosis Linked to Xenobiotic Exposure: Holistic Approach.
    Torres-Sánchez A; Ruiz-Rodríguez A; Ortiz P; Moreno MA; Ampatzoglou A; Gruszecka-Kosowska A; Monteoliva-Sánchez M; Aguilera M
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiota analysis for risk assessment of xenobiotics: cumulative xenobiotic exposure and impact on human gut microbiota under One Health approach.
    Gruszecka-Kosowska A; Ampatzoglou A; Aguilera-Gómez M
    EFSA J; 2022 Dec; 20(Suppl 2):e200916. PubMed ID: 36531282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicomicrobiomics: The Human Microbiome vs. Pharmaceutical, Dietary, and Environmental Xenobiotics.
    Abdelsalam NA; Ramadan AT; ElRakaiby MT; Aziz RK
    Front Pharmacol; 2020; 11():390. PubMed ID: 32372951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiota analysis for risk assessment of xenobiotic exposure and the impact on dysbiosis: identifying potential next-generation probiotics.
    López-Moreno A; Langella P; Martín R; Aguilera M
    EFSA J; 2023 Nov; 21(Suppl 1):e211010. PubMed ID: 38047127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Gut Microbiome and Xenobiotics: Identifying Knowledge Gaps.
    Sutherland VL; McQueen CA; Mendrick D; Gulezian D; Cerniglia C; Foley S; Forry S; Khare S; Liang X; Manautou JE; Tweedie D; Young H; Alekseyenko AV; Burns F; Dietert R; Wilson A; Chen C
    Toxicol Sci; 2020 Jul; 176(1):1-10. PubMed ID: 32658296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical transformation of xenobiotics by the human gut microbiota.
    Koppel N; Maini Rekdal V; Balskus EP
    Science; 2017 Jun; 356(6344):. PubMed ID: 28642381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Connecting the dots: Targeting the microbiome in drug toxicity.
    Luo Y; Zhou T
    Med Res Rev; 2022 Jan; 42(1):83-111. PubMed ID: 33856076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut Reactions: Breaking Down Xenobiotic-Microbiome Interactions.
    Clarke G; Sandhu KV; Griffin BT; Dinan TG; Cryan JF; Hyland NP
    Pharmacol Rev; 2019 Apr; 71(2):198-224. PubMed ID: 30890566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xenobiotics: Interaction with the Intestinal Microflora.
    Lu K; Mahbub R; Fox JG
    ILAR J; 2015; 56(2):218-27. PubMed ID: 26323631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early-life chemical exposome and gut microbiome development: African research perspectives within a global environmental health context.
    Ayeni KI; Berry D; Wisgrill L; Warth B; Ezekiel CN
    Trends Microbiol; 2022 Nov; 30(11):1084-1100. PubMed ID: 35697586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probiotics as a biological detoxification tool of food chemical contamination: A review.
    Średnicka P; Juszczuk-Kubiak E; Wójcicki M; Akimowicz M; Roszko MŁ
    Food Chem Toxicol; 2021 Jul; 153():112306. PubMed ID: 34058235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiomes in physiology: insights into 21st-century global medical challenges.
    Shehata E; Parker A; Suzuki T; Swann JR; Suez J; Kroon PA; Day-Walsh P
    Exp Physiol; 2022 Apr; 107(4):257-264. PubMed ID: 35081663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of Intestinal Microbiota with Medications.
    Liu M; Xu J; Jin Q; Li Y
    Curr Drug Metab; 2023; 24(8):554-567. PubMed ID: 37073652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host-microbiome metabolism of a plant toxin in bees.
    Motta EVS; Gage A; Smith TE; Blake KJ; Kwong WK; Riddington IM; Moran N
    Elife; 2022 Dec; 11():. PubMed ID: 36472498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of xenobiotic-induced gut microbiota dysbiosis: from correlation to mechanisms.
    Chi L; Tu P; Ru H; Lu K
    Gut Microbes; 2021; 13(1):1921912. PubMed ID: 34313531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Review on Selected Xenobiotics and Their Impacts on Gut Microbiome and Metabolome.
    Jin Y; Chi J; LoMonaco K; Boon A; Gu H
    Trends Analyt Chem; 2023 Sep; 166():. PubMed ID: 37484879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revealing proteome-level functional redundancy in the human gut microbiome using ultra-deep metaproteomics.
    Li L; Wang T; Ning Z; Zhang X; Butcher J; Serrana JM; Simopoulos CMA; Mayne J; Stintzi A; Mack DR; Liu YY; Figeys D
    Nat Commun; 2023 Jun; 14(1):3428. PubMed ID: 37301875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diverse mechanisms by which chemical pollutant exposure alters gut microbiota metabolism and inflammation.
    Teffera M; Veith AC; Ronnekleiv-Kelly S; Bradfield CA; Nikodemova M; Tussing-Humphreys L; Malecki K
    Environ Int; 2024 Aug; 190():108805. PubMed ID: 38901183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.